Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pylera

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND Several studies have shown that Pylera® (three-in-one capsules containing 140 mg bismuth potassium subcitrate, 125… Expand
Is this relevant?
2019
2019
BACKGROUND Bismuth is no longer available in Europe except as part of combination therapy. Lactobacillus reuteri has also been… Expand
Is this relevant?
2018
2018
Background: Our aims were to assess the real life effectiveness and safety of the new bismuth-containing quadruple therapy in a… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2018
2018
Resumen Objetivo La resistencia de Helicobacter pylori a los antibioticos es un problema creciente en nuestro medio y es… Expand
Is this relevant?
2018
2018
Abstract Objective The resistance of Helicobacter pylori to antibiotics is a growing problem in Spain and eradication rates must… Expand
Is this relevant?
2017
2017
Pylera® comprises three (bismuth substrate potassium + metronidazole + tetracycline hydrochloride) of four components of bismuth… Expand
Is this relevant?
Review
2017
Review
2017
Background Helicobacter pylori antibiotic resistance is an increasing problem worldwide. Pylera® may be an option as salvage… Expand
Is this relevant?
Review
2017
Review
2017
BACKGROUND Helicobacter pylori antibiotic resistance is an increasing problem worldwide. Pylera® may be an option as salvage… Expand
Is this relevant?
Review
2009
Review
2009
An ideal antibiotic regimen for Helicobacter pylori should achieve eradication rates of approximately 90%. Current 7-day triple… Expand
Is this relevant?